Advancing Access: Blood Cancers & The Black Community
3915 Beryl Rd
3915 Beryl Road
Raleigh, NC 27607
Thursday, November 13, 2025 at 6:00pm ET - 8:00pm ET
Add this event to your calendar
Info
Topic
Myeloma, Blood Cancers, Health Equity, Clinical Trials
Additional Information
Join us for a community talk on myeloma & blood cancers in the Black community. Learn about screening & care, self-advocacy tips, and how access & equity in research leads to better treatments. Dinner included.
Speakers

Hematology Oncology Fellow
Dr. Coring is a practicing physician fellow at Duke Cancer Institute, and an aspiring Multiple Myeloma Specialist. He began his professional journey into healthcare as a clinical pharmacist, before embracing his curiosities and pursuing medicine. More than Dr. Coring’s role as a Physician, he is also an effective community leader with extensive experience educating patients and the community about cancer and cancer prevention, improving health literacy, and caring for patients along their Multiple Myeloma journey.

Clinical Research Coordinator
Amber Erskine is a Clinical Research Coordinator at UNC Lineberger Comprehensive Cancer Center with a decade of experience in clinical research across multiple specialties. She completed her Master of Healthcare Leadership at Brown University, where her work emphasized advancing equity and representation in clinical trials. Amber is committed to strengthening research systems to improve access, inclusion, and outcomes for historically underrepresented patient populations.

Clinical Research Coordinator
Miya Kitt is a clinical trial coordinator with over 5 years of experience specializing in Leukemia at UNC Lineberger Comprehensive Cancer Center. Miya brings extensive experience across multiple research areas, with a current focus on leukemia clinical trials studies. Miya combines practical clinical research expertise with a strong commitment to fostering inclusive, patient-centered care. With this commitment, she enhances clinical operations and helps guide the future of patient-centered research.